Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Overview
News
Currencies
International
Treasuries

Affimed Ord Shs (NQ: AFMD )

3.260 +0.030 (+0.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Affimed Ord Shs

< Previous 1 2 3 4 5 6 Next >
Affimed Announces 1-for-10 Reverse Stock Split
From Affimed N.V.
Via GlobeNewswire
Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Leadership Change and Organizational Restructuring
From Affimed N.V.
Via GlobeNewswire
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter. 
Via Benzinga
Recap: Affimed Q3 Earnings
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers with all of the latest coverage worth reading about on Wednesday morning! 
Via InvestorPlace
Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
From Affimed N.V.
Via GlobeNewswire
3 Penny Stocks That Are Too Compelling to Ignore
Although the sector presents extraordinary risks, for those seeking extreme returns, these top penny stocks to buy could get it done. 
Via InvestorPlace
Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer Patients
From Affimed N.V.
Via GlobeNewswire
Earnings Outlook For Affimed
Via Benzinga
What 6 Analyst Ratings Have To Say About Affimed
Via Benzinga
Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)
From Affimed N.V.
Via GlobeNewswire
Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24
From Affimed N.V.
Via GlobeNewswire
Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
From Affimed N.V.
Via GlobeNewswire
Expert Ratings for Affimed
Via Benzinga
Affimed Announces Acimtamig as International Nonproprietary Name for AFM13
From Affimed N.V.
Via GlobeNewswire
Affimed to Report Third Quarter 2023 Financial Results & Corporate Update on November 14, 2023
From Affimed N.V.
Via GlobeNewswire
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the trading week right with a breakdown of the biggest pre-market stock movers worth noting on Monday morning! 
Via InvestorPlace
Affimed Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting
From Affimed N.V.
Via GlobeNewswire
Affimed to Participate in Upcoming Investor Conferences
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Listing Transfer to Nasdaq Capital Markets
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Acceptance of an Abstract Comparing NK Cells Redirected by Innate Cell Engagers and CAR-NK Cells for Poster Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
From Affimed N.V.
Via GlobeNewswire
Affimed to Present at the Cantor Global Healthcare Conference 2023
From Affimed N.V.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day off with a breakdown of the biggest pre-market stock movers worth watching on Tuesday morning! 
Via InvestorPlace
Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma
From Affimed N.V.
Via GlobeNewswire
Affimed to Present at the H.C. Wainwright Annual Global Investment Conference
From Affimed N.V.
Via GlobeNewswire
Surprise! These 3 Penny Stocks Have Wall Street’s Seal of Approval.
While speculative securities are a dime a dozen, these top Wall Street penny stocks offer a measure of confidence for the curious. 
Via InvestorPlace
Affimed Announces Publication in the Journal mAbs on Leveraging FcRn-pH-HPLC as a Method to Select Bispecific Antibodies with Optimal Developability
From Affimed N.V.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.